Scott G Franzblau

24PUBLICATIONS

71CO-AUTHORS

Biologically active moleculesBiomolecular modelling and designGene and molecular therapyGlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (24)

Sort by Publication Date:

|Jun 26, 2026

Biological Evaluation of Esters of 4-Carboxylate-1,2,3-triazine and Analogs as New Potential Anti-Mycobacterium tuberculosis Agents.

|Dec 12, 2025

Unique Interactions of Novel Rufomycin "Click Chemistry" Analogs with Mtb ClpC1 and Implications.

Kiira Ratia, Shengnan Jin, Celerino Abad-Zapatero

|Dec 03, 2025

Selectivity of the Time-Dependent M. tuberculosis LeuRS Inhibitor Ganfeborole Is Driven by Target Vulnerability.

Mingqian Wang, YongLe He, Siobhan A Cohen

|Mar 24, 2025

Structure-Based Analysis of Semisynthetic Anti-TB Rufomycin Analogues.

Bin Zhou, Gauri Shetye, Larry L Klein

|Feb 14, 2025

Expanding the Landscape of Dual Action Antifolate Antibacterials through 2,4-Diamino-1,6-dihydro-1,3,5-triazines.

John D Georgiades, Daniel A Berkovich, Samuel R McKee

|Nov 11, 2024

Discovery of New Cyclic Lipodepsipeptide Orfamide N via Partnership with Middle School Students from the Boys and Girls Club.

Jin Yi Tan, Mario Augustinović, Ashraf M Omar

Pageof 4

Frequent Collaborators

Guido Pauli

James McAlpine

Sanghyun Cho

Shao-Nong Chen

Hyun Lee

Mary P Choules

Bin Zhou

David C Lankin

Birgit U Jaki

Isidro Palos

Frequent Collaborators

Guido Pauli

James McAlpine

Sanghyun Cho

Shao-Nong Chen